Clinical Trial Update: Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA [Phase 3]

View source ↗

Summary

Phase 3 randomized study assessing different dosages of rabbit anti-thymocyte globulin (ATG-R) in patients with Acquired Aplastic Anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Aplastic Anemia

Drugs mentioned

• Rabbit anti-thymocyte globulin (ATG-R) (antithymocyte globulin, rabbit origin)

Snippet

Sponsor: Nagoya University | Conditions: Acquired Aplastic Anemia. | Phase 3 | Status: UNKNOWN